We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020

By LabMedica International staff writers
Posted on 05 Feb 2020
Print article
Illustration
Illustration
Erba Mannheim (London, UK) launched its new electrolyte analyzer, EC 90 with maintenance-free electrodes in an all-in-one sensor cartridge, at MEDLAB 2020. Additionally, Erba launched new immunoassays, clinical chemistry, diabetes and hematology products designed to boost productivity of small and medium sized labs. The company also provided a preview of its NEXUS range of next generation total lab automation solutions.

The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. A "plug and play" sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na[+] and Cl-, 0.01mmol/L for K[+] and Ca[2+] and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, < 8kg), the EC 90 comes with an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.

Alongside the EC 90, Erba launched the new HB715 automated desktop analyzer for measuring glycated hemoglobin (HbA1c, HbA1ab, HbA1c, HbF, HbA0, HbA2/E/D, HbS, HbC) and designed for ease of use and low-cost operation. Erba also launched its new ELAN 30s analyzer, a fully automated compact benchtop ELISA microstrip processor that can perform six different tests simultaneously, and Rapid Malaria and Dengue Tests with unique Dual Color Detection system. In hematology, the company launched the new ESL 30, a fully automated ESR testing solution that improves result quality, laboratory safety and efficiency in mid-sized labs at an affordable price. Alongside the new products, Erba presented the updated versions of its signature XL 200 and XL 640+ clinical chemistry analyzers.

Additionally, Erba provided a preview of its next generation NEXUS total lab automation system which will offer powerful, modular solutions using advanced imaging and artificial intelligence. The NEXUS IA immunoassay analyzer uses unique magnetic CLIA bead technology and extensive panels to deliver a reliable and affordable solution, while the Nexus H Infinity Hematology analyzer uses computer vision to actually 'see' the sample and provides advanced diagnostics by counting, staining, imaging and analyzing 1000's of cells in less than a minute.

"At MEDLAB ME, we continue to demonstrate our commitment to becoming a leading player in the IVD market. With NEXUS we offer a unique entry level system for Total Lab Automation, enabling labs to scale their business with higher automation. Also, by significantly strengthening our product portfolio for small and medium sized labs and growing our global customer base, we are well placed to achieve our ambition," said Romain Fournials, CCO of Erba Mannheim.

Related Links:
Erba Mannheim

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.